Detalles de la búsqueda
1.
Transforming primary human hepatocytes into hepatocellular carcinoma with genetically defined factors.
EMBO Rep
; 23(6): e54275, 2022 06 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35437924
2.
Exploring the effect of Wuzhi capsule on the pharmacokinetics of regorafenib and its main metabolites in rat plasma using liquid chromatography-tandem mass spectrometry.
J Sep Sci
; 47(5): e2300923, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38466147
3.
Evaluating linezolid dose regimens against methicillin-resistant Staphylococcus aureus based on renal function in populations with different body weight.
J Clin Pharm Ther
; 47(12): 2162-2169, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36053892
4.
Assessment of micafungin loading dosage regimens against Candida spp. in ICU patients by Monte Carlo simulations.
Eur J Clin Pharmacol
; 76(5): 695-702, 2020 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-32047965
5.
Predictable Resistance and Overall Survival of Gemcitabine/Cisplatin by Platelet Activation Index in Non-Small Cell Lung Cancer.
Med Sci Monit
; 24: 8655-8668, 2018 Nov 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-30498189
6.
Dose regimens for Chinese adult liver transplant recipients according to the genetic polymorphisms of CYP2C9, CYP2C19, and CYP3A5 in recipients and donors.
Int J Clin Pharmacol Ther
; 54(8): 587-96, 2016 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-27191765
7.
A pharmacokinetic/pharmacodynamic analysis of a standard voriconazole regimen in different CYP2C19 genotypes by Monte Carlo simulation.
Pharmazie
; 70(5): 306-9, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-26062298
8.
Evaluation of omadacycline regimens for community-acquired bacterial pneumonia patients infected with Staphylococcus Aureus by pharmacokinetic/pharmacodynamic analysis.
J Chemother
; : 1-8, 2024 Apr 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38650393
9.
Cost-effectiveness analysis of tislelizumab plus chemotherapy as the first-line treatment for advanced or metastatic oesophageal squamous cell carcinoma in China.
PLoS One
; 19(5): e0302961, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38748691
10.
A Prognostic Cuproptosis-Related LncRNA Signature for Colon Adenocarcinoma.
J Oncol
; 2023: 5925935, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36844874
11.
Population Pharmacokinetics of Tacrolimus in Pediatric Patients With Umbilical Cord Blood Transplant.
J Clin Pharmacol
; 63(3): 298-306, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36196568
12.
Dose-sparing effect of lapatinib co-administered with a high-fat enteral nutrition emulsion: preclinical pharmacokinetic study.
PeerJ
; 11: e16207, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37842056
13.
Population pharmacokinetics and toxicity correlation analysis of free and liposome-encapsulated doxorubicin in Chinese patients with advanced breast cancer.
Cancer Chemother Pharmacol
; 92(3): 181-192, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37378676
14.
Correlation of gene expression profiles to identify pancreatic cancer cell lines that best model primary human tumors.
Transl Cancer Res
; 12(4): 980-991, 2023 Apr 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-37180676
15.
Population Pharmacokinetics of Anlotinib, a Multiple Receptor Tyrosine Kinase Inhibitor, in Chinese Patients With Malignant Tumors.
J Clin Pharmacol
; 63(7): 830-837, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37016894
16.
Cost-effectiveness analysis of durvalumab plus etoposide: platinum in the first-line therapy of extensive stage small-cell lung cancer from the Chinese payers' perspective.
Tumori
; 108(1): 33-39, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33511911
17.
Modified microvessel density based on perfusion distance: a preferable NSCLC prognostic factor.
Ann Transl Med
; 10(2): 43, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-35282046
18.
Underlying mechanism of sorafenib resistance in hepatocellular carcinoma: a bioinformatics study based on validated resistance-related genes.
J Gastrointest Oncol
; 12(4): 1895-1904, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-34532137
19.
Cost effectiveness of immune checkpoint inhibitors for treatment of non-small cell lung cancer: A systematic review.
PLoS One
; 15(9): e0238536, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32877435
20.
Cost-effectiveness of pembrolizumab for treatment of platinum-resistant recurrent or metastatic head and neck squamous cell carcinoma in China: an economic analysis based on a randomised, open-label, phase III trial.
BMJ Open
; 10(12): e038867, 2020 12 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-33371020